Stay updated on Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.

Latest updates to the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows an updated ClinicalTrials.gov site revision/version number (v3.5.3 rather than v3.5.2).SummaryDifference0.0%

- Check17 days agoChange DetectedRevision updated to v3.5.2.SummaryDifference0.0%

- Check25 days agoNo Change Detected
- Check46 days agoChange DetectedRevision labels updated from v3.4.3 to v3.5.0. No study content or data appear to be affected.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision notice updated to v3.4.3. The previous revision v3.4.2 is no longer displayed.SummaryDifference0.0%

- Check82 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, indicating a minor version update in the study documents. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision: v3.4.1 has been added and Revision: v3.4.0 has been removed, indicating a minor version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib Study in RA Patients: China & Global Countries Clinical Trial page.